# Irinotecan Hydrochloride

NDC: 60505-6272
Generic name: Irinotecan Hydrochloride
Labeler / Manufacturer: Apotex Corp.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230701

FDA application: ANDA203380

## Active ingredients

- IRINOTECAN HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-6272"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-6272
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fe98987-e526-4729-a8f4-c7230f424108